Handelsbanken Fonder
ONEM

Handelsbanken Fonder’s 1Life Healthcare ONEM Stock Holding History

Handelsbanken Fonder’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,500
Closed -$359K – 1598
2022
Q4 		$359K Hold
21,500
– – ﹤0.01% 1149
2022
Q3 		$369K Hold
21,500
– – ﹤0.01% 1129
2022
Q2 		$169K Buy
21,500
+200
+0.9% +$1.72K ﹤0.01% 1520
2022
Q1 		$236K Hold
21,300
– – ﹤0.01% 1598
2021
Q4 		$374K Buy
21,300
+3,800
+22% +$73.7K ﹤0.01% 1529
2021
Q3 		$354K Hold
17,500
– – ﹤0.01% 1537
2021
Q2 		$579K Buy
17,500
+1,400
+9% +$52.8K ﹤0.01% 1272
2021
Q1 		$629K Buy
16,100
+900
+6% +$42.3K ﹤0.01% 1071
2020
Q4 		$663K Buy
15,200
+8,100
+114% +$277K ﹤0.01% 1007
2020
Q3 		$201K Buy
+7,100
New +$224K ﹤0.01% 1388

Handelsbanken Fonder's ONEM Position: Q1 2023 in Review

Handelsbanken Fonder sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 21,500 shares — an estimated $359K sold.

Handelsbanken Fonder first reported a position in ONEM in Q3 2020 and held it in 10 quarters. The position peaked at $663K in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Handelsbanken Fonder reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 21,500 1Life Healthcare shares in Q1 2023, an estimated $359K.
  • Handelsbanken Fonder first reported a position in 1Life Healthcare in Q3 2020 and held it in 10 quarters.
  • Handelsbanken Fonder's 1Life Healthcare position peaked at $663K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Handelsbanken Fonder's 13F filing for Q1 2023, filed 28 Apr 2023.